Additional Details

  • A Study to Investigate Leramistat in Patients With IPF

    UCSF Fresno
    Fresno CA. 93701-2302
    View Details

  • A Study to Investigate Leramistat in Patients With IPF

    US Associates in Research Inc
    Miami FL. 33175
    View Details

  • A Study to Investigate Leramistat in Patients With IPF

    Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas
    Dallas TX. 75246-2073
    View Details

  • A Study to Investigate Leramistat in Patients With IPF

    Howard County Center for Lung and Sleep Medicine, LLC
    Columbia MD. 21044-3081
    View Details

  • A Study to Investigate Leramistat in Patients With IPF

    Hudson County Clinical Trials Research Center
    Union City NJ. 07087-3375
    View Details

  • A Study to Investigate Leramistat in Patients With IPF

    MedStar Georgetown University Hospital
    Washington DC. 20007
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Stamford Health Medical Group - Stamford - 29 Hospital Plaza Suite 605
    Stamford CT. 06904
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Avanza Medical Research Center
    Pensacola FL. 32503
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Scripps Clinic Torrey Pines
    La Jolla CA. 92037-1027
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    The University of Texas Health San Antonio Medical Arts & Research Center
    San Antonio TX. 78229-3931
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Emory Clinic
    Atlanta GA. 30322-1013
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0526
    Tucson AZ. 85723-3001
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Loyola University Health System
    Maywood IL. 60153-3328
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    University of Cincinnati College Of Medicine
    Cincinnati OH. 45267
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0525
    Reno NV. 89502-1576
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    St. Paul's Hospital
    Vancouver BC. V6Z 1Y6
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    University of Southern California (USC) - Keck School of Medicine (KSOM) - Transplant Clinic
    Los Angeles CA. 90033-5313
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0517
    Miami FL. 33136-1124
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    David Geffen School of Medicine at UCLA
    Los Angeles CA. 90095-3075
    View Details